Provided by Tiger Trade Technology Pte. Ltd.

AIxCrypto Holdings, Inc.

1.12
-0.0550-4.68%
Post-market: 1.10-0.0200-1.79%19:59 EDT
Volume:492.11K
Turnover:594.08K
Market Cap:22.66M
PE:-0.38
High:1.30
Open:1.24
Low:1.11
Close:1.18
52wk High:8.81
52wk Low:0.5930
Shares:20.23M
Float Shares:20.11M
Volume Ratio:0.03
T/O Rate:2.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9479
EPS(LYR):-8.1106
ROE:-1136.66%
ROA:-134.37%
PB:83.25
PE(LYR):-0.14

Loading ...

Company Profile

Company Name:
AIxCrypto Holdings, Inc.
Exchange:
NASDAQ
Establishment Date:
1996
Employees:
10
Office Location:
1990 E Grand Ave,El Segundo,California,United States
Zip Code:
90245
Fax:
- -
Introduction:
Qualigen Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Directors

Name
Position
Chad Chen
Independent Director
Chen Shi
Independent Director
Kevin Chen
Independent Director

Shareholders

Name
Position
Jiawei Wang
Chief Executive Officer
Jie Sheng
Chief Financial Officer and President